US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.350
-0.040-2.88%

Trading Nov 27 14:12 ET

40.34MMarket Cap-678P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-24.55%93.43M

9.74%104.54M

29.03%114.21M

11.70%107.3M

18.62%123.82M

-15.99%95.26M

-25.21%88.52M

64.05%96.06M

-Cash and cash equivalents

2.72%33.5M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

-Short-term investments

-34.30%59.92M

42.84%77.77M

44.84%89.52M

33.13%91.65M

20.67%91.2M

-25.18%54.45M

72.47%61.81M

48.18%68.84M

Other current assets

64.53%4.26M

-1.70%2.9M

16.77%2.1M

25.37%3.21M

-11.08%2.59M

-15.48%2.95M

26.03%1.8M

65.18%2.56M

Total current assets

-22.72%97.69M

9.40%107.44M

28.78%116.31M

12.05%110.51M

17.81%126.41M

-15.97%98.21M

-24.60%90.32M

64.08%98.62M

Non current assets

Investments and advances

--0

--3.9M

744.80%27.19M

1,223.09%26.36M

--0

-7.66%3.22M

Non current deferred assets

----

--48K

----

Other non current assets

----

44.86%1.04M

0.00%720K

--720K

Total non current assets

--0

44.86%1.04M

544.14%4.95M

616.86%28.24M

910.29%27.4M

-77.06%720K

6.67%768K

-24.40%3.94M

Total assets

-36.49%97.69M

9.66%108.48M

33.13%121.26M

35.28%138.74M

39.82%153.81M

-17.57%98.93M

-24.41%91.08M

57.02%102.56M

Liabilities

Current liabilities

Payables

-64.92%1.71M

-39.80%1.89M

-31.37%2.43M

26.11%2.68M

238.68%4.88M

94.23%3.13M

35.88%3.55M

99.62%2.12M

-accounts payable

-64.92%1.71M

-39.80%1.89M

-31.37%2.43M

26.11%2.68M

238.68%4.88M

94.23%3.13M

35.88%3.55M

99.62%2.12M

Current accrued expenses

-27.53%4.92M

-9.31%5.84M

63.03%6.91M

135.50%6.68M

276.18%6.79M

257.55%6.44M

101.86%4.24M

102.79%2.84M

Current debt and capital lease obligation

----

0.00%13K

6.25%34K

--53K

-Current capital lease obligation

----

--0

0.00%13K

6.25%34K

--53K

Other current liabilities

30.64%1.28M

18,533.33%559K

6,320.00%321K

11,033.33%668K

12,100.00%976K

-66.67%3K

-50.00%5K

-64.71%6K

Current liabilities

-32.50%10.02M

-9.26%10.13M

24.48%10.66M

95.42%14.04M

234.81%14.84M

169.00%11.16M

68.39%8.57M

111.66%7.19M

Non current liabilities

Derivative product liabilities

----

--0

-75.00%1K

-83.33%1K

-84.62%2K

Total non current liabilities

--0

-75.00%1K

-83.33%1K

-84.62%2K

Total liabilities

-32.50%10.02M

-9.27%10.13M

24.47%10.66M

95.37%14.04M

234.59%14.84M

168.77%11.16M

68.21%8.57M

110.92%7.19M

Shareholders'equity

Share capital

--0

-common stock

--0

-Preferred stock

--0

Retained earnings

-44.12%-198.25M

-53.50%-185.51M

-62.85%-171.07M

-72.15%-154.46M

-76.62%-137.56M

-81.61%-120.85M

-86.18%-105.05M

-89.35%-89.72M

Paid-in capital

3.31%285.81M

36.01%283.89M

50.00%281.62M

50.37%278.88M

50.36%276.65M

14.21%208.73M

9.16%187.74M

--185.47M

Gains losses not affecting retained earnings

191.80%112K

77.31%-27K

130.29%53K

173.53%275K

77.45%-122K

66.94%-119K

-10.76%-175K

-1,285.19%-374K

Total stockholders'equity

-36.91%87.67M

12.07%98.35M

34.03%110.6M

30.75%124.7M

31.63%138.97M

-24.25%87.76M

-28.50%82.52M

54.05%95.37M

Total equity

-36.91%87.67M

12.07%98.35M

34.03%110.6M

30.75%124.7M

31.63%138.97M

-24.25%87.76M

-28.50%82.52M

54.05%95.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-24.55%93.43M	9.74%104.54M	29.03%114.21M	11.70%107.3M	11.70%107.3M	18.62%123.82M	-15.99%95.26M	-25.21%88.52M	64.05%96.06M	64.05%96.06M
-Cash and cash equivalents	2.72%33.5M	-34.41%26.77M	-7.55%24.69M	-42.51%15.65M	-42.51%15.65M	13.24%32.62M	0.48%40.81M	-67.63%26.71M	125.01%27.22M	125.01%27.22M
-Short-term investments	-34.30%59.92M	42.84%77.77M	44.84%89.52M	33.13%91.65M	33.13%91.65M	20.67%91.2M	-25.18%54.45M	72.47%61.81M	48.18%68.84M	48.18%68.84M
Other current assets	64.53%4.26M	-1.70%2.9M	16.77%2.1M	25.37%3.21M	25.37%3.21M	-11.08%2.59M	-15.48%2.95M	26.03%1.8M	65.18%2.56M	65.18%2.56M
Total current assets	-22.72%97.69M	9.40%107.44M	28.78%116.31M	12.05%110.51M	12.05%110.51M	17.81%126.41M	-15.97%98.21M	-24.60%90.32M	64.08%98.62M	64.08%98.62M
Non current assets
Investments and advances	--0	--0	--3.9M	744.80%27.19M	744.80%27.19M	1,223.09%26.36M	--0	--0	-7.66%3.22M	-7.66%3.22M
Non current deferred assets	----	----	----	----	----	----	----	--48K	----	----
Other non current assets	----	44.86%1.04M	44.86%1.04M	44.86%1.04M	44.86%1.04M	44.86%1.04M	0.00%720K	0.00%720K	--720K	--720K
Total non current assets	--0	44.86%1.04M	544.14%4.95M	616.86%28.24M	616.86%28.24M	910.29%27.4M	-77.06%720K	6.67%768K	-24.40%3.94M	-24.40%3.94M
Total assets	-36.49%97.69M	9.66%108.48M	33.13%121.26M	35.28%138.74M	35.28%138.74M	39.82%153.81M	-17.57%98.93M	-24.41%91.08M	57.02%102.56M	57.02%102.56M
Liabilities
Current liabilities
Payables	-64.92%1.71M	-39.80%1.89M	-31.37%2.43M	26.11%2.68M	26.11%2.68M	238.68%4.88M	94.23%3.13M	35.88%3.55M	99.62%2.12M	99.62%2.12M
-accounts payable	-64.92%1.71M	-39.80%1.89M	-31.37%2.43M	26.11%2.68M	26.11%2.68M	238.68%4.88M	94.23%3.13M	35.88%3.55M	99.62%2.12M	99.62%2.12M
Current accrued expenses	-27.53%4.92M	-9.31%5.84M	63.03%6.91M	135.50%6.68M	135.50%6.68M	276.18%6.79M	257.55%6.44M	101.86%4.24M	102.79%2.84M	102.79%2.84M
Current debt and capital lease obligation	----	----	----	----	----	----	0.00%13K	6.25%34K	--53K	--53K
-Current capital lease obligation	----	----	----	--0	--0	--0	0.00%13K	6.25%34K	--53K	--53K
Other current liabilities	30.64%1.28M	18,533.33%559K	6,320.00%321K	11,033.33%668K	11,033.33%668K	12,100.00%976K	-66.67%3K	-50.00%5K	-64.71%6K	-64.71%6K
Current liabilities	-32.50%10.02M	-9.26%10.13M	24.48%10.66M	95.42%14.04M	95.42%14.04M	234.81%14.84M	169.00%11.16M	68.39%8.57M	111.66%7.19M	111.66%7.19M
Non current liabilities
Derivative product liabilities	----	----	----	--0	--0	--0	-75.00%1K	-83.33%1K	-84.62%2K	-84.62%2K
Total non current liabilities	--0	--0	--0	--0	--0	--0	-75.00%1K	-83.33%1K	-84.62%2K	-84.62%2K
Total liabilities	-32.50%10.02M	-9.27%10.13M	24.47%10.66M	95.37%14.04M	95.37%14.04M	234.59%14.84M	168.77%11.16M	68.21%8.57M	110.92%7.19M	110.92%7.19M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-44.12%-198.25M	-53.50%-185.51M	-62.85%-171.07M	-72.15%-154.46M	-72.15%-154.46M	-76.62%-137.56M	-81.61%-120.85M	-86.18%-105.05M	-89.35%-89.72M	-89.35%-89.72M
Paid-in capital	3.31%285.81M	36.01%283.89M	50.00%281.62M	50.37%278.88M	50.37%278.88M	50.36%276.65M	14.21%208.73M	9.16%187.74M	--185.47M	--185.47M
Gains losses not affecting retained earnings	191.80%112K	77.31%-27K	130.29%53K	173.53%275K	173.53%275K	77.45%-122K	66.94%-119K	-10.76%-175K	-1,285.19%-374K	-1,285.19%-374K
Total stockholders'equity	-36.91%87.67M	12.07%98.35M	34.03%110.6M	30.75%124.7M	30.75%124.7M	31.63%138.97M	-24.25%87.76M	-28.50%82.52M	54.05%95.37M	54.05%95.37M
Total equity	-36.91%87.67M	12.07%98.35M	34.03%110.6M	30.75%124.7M	30.75%124.7M	31.63%138.97M	-24.25%87.76M	-28.50%82.52M	54.05%95.37M	54.05%95.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data